ArticlePlant biotechnology journal2026
High yield production of the antifungal proteins PeAfpA and PdAfpB by vacuole targeting in a TMV-based expression vector.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Optimisation and Scale-Up of the Heterologous Production of the Antifungal Protein PeAfpA From Penicillium expansum in Stirred-Tank Bioreactors.Microbial biotechnology · 2026Article
- Engineering Penicillium expansum antifungal proteins unveils new clues about their mode of action.Applied microbiology and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Antifungal proteins (AFPs) derived from filamentous fungi show great potential against economically significant fungi that cause plant diseases and consequently threat food safety and security. This study focuses on the Penicillium expansum PeAfpA and Penicillium digitatum PdAfpB proteins and their activity against several phytopathogens. The AFPs were synthesized through a highly productive tobacco mosaic virus-based expression vector in the fast-growing model plant Nicotiana benthamiana, combining signalling sequences for apoplastic and vacuolar compartmentalization to increase yields. Adding a vacuolar signalling peptide from a Nicotiana sylvestris chitinase at the C-termini of the AFPs in combination with an apoplastic N-terminal signalling peptide from N. benthamiana osmotin significantly enhanced AFP yields without altering functionality. Results showed an improvement of ninefold for PeAfpA and 3,5-fold for PdAfpB compared to constructs with only the apoplastic N-terminal signalling. Transmission electron microscopy and immunogold labelling confirmed the localization of AFPs in both the apoplast and the vacuole, highlighting its compatibility with vacuolar environments. In vitro and in vivo assessments against key pathogenic fungi, including Magnaporthe oryzae, Botrytis cinerea and Fusarium proliferatum, revealed that the activities of easily purified PeAfpA- and PdAfpB-enriched plant extracts closely mirrored those of their purified fungal counterparts. This innovative approach represents a notable advance towards the application of AFPs as effective, safe and environmentally friendly 'green biofungicides' for safeguarding crop and postharvest produce and could also be applied to control other pathogenic fungi that threat human health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.